|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Hepatitis D Virus RNA, Quantitative, Real-Time PCR
Test Code37889
CPT Codes
87523
Preferred Specimen
2 mL serum collected in a plastic screw-cap vial
Minimum Volume
0.6 mL
Instructions
Separate serum from whole blood within 24 hours. Freshly collected whole blood may be stored at 2-25° C for up to 24 hours before separation. Serum should be transported frozen on dry ice in transport tubes.
Transport Container
Transport tube
Transport Temperature
Frozen
Specimen Stability
Room temperature: 24 hours
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Serum not separated from whole blood
Methodology
Real-Time Polymerase Chain Reaction
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon-Sat; Report Available: 4 days
Reference Range
Hepatitis D Virus RNA, QN, RT PCR | Not Detected (IU/mL) |
Hepatitis D Virus RNA, QN, PCR | Not Detected (Log IU/mL) |
Clinical Significance
Hepatitis D virus (HDV) infection requires the surface antigen from HBV and may occur as an acute infection with HBV or as a superinfection of a chronic HBV infection. HDV should be considered in any individual who tests positive for the HBV surface antigen (HBsAg). The presence of HDV RNA in the serum reflects viral replication in the liver. HDV-HBV co-infection is considered the most severe form of chronic viral hepatitis due to more rapid progression towards liver-related death and hepatocellular carcinoma. HDV RNA, quantitative real-time PCR can assist with diagnosis of HDV infection as well as monitoring of treatment.